COVID-19 Impact on Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Insights, Forecast to 2026
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is segmented into
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Analysis
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) business, the date to enter into the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is segmented into
- Control Hyperphosphatemia
- Maintain Blood Calcium Levels
- Control PTH Level
- Correct Acidosis
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Other
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share Analysis
Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) business, the date to enter into the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) product introduction, recent developments, etc.
The major vendors covered:
- Akebia
- Astellas
- Takeda
- Vifor
- Abbvie
- Fresenius
- Abbott
- Novadiol
- Japan Tobacco Company
- Daiichi-Sankyo
- Shield
- Spectrum
- OPKO
- Ardelyx
- Sanofi Genzyme
- Amgen
1 STUDY COVERAGE
1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Type
1.4.2 Control Hyperphosphatemia
1.4.3 Maintain Blood Calcium Levels
1.4.4 Control PTH Level
1.4.5 Correct Acidosis
1.4.6 Other
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Impact
1.6.1 How the Covid-19 is Affecting the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry
1.6.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2015-2026
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2020 Versus 2026
2.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers
3.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2015-2020)
3.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers
3.2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue in 2019
3.2.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Manufacturers
3.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2015-2020)
5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
6.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Region
8.1.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
8.1.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
8.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
9.1.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
9.1.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
9.3 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
10.1.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
10.1.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Akebia
11.1.1 Akebia Corporation Information
11.1.2 Akebia Description, Business Overview and Total Revenue
11.1.3 Akebia Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.1.5 Akebia Recent Development
11.2 Astellas
11.2.1 Astellas Corporation Information
11.2.2 Astellas Description, Business Overview and Total Revenue
11.2.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.2.5 Astellas Recent Development
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description, Business Overview and Total Revenue
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.3.5 Takeda Recent Development
11.4 Vifor
11.4.1 Vifor Corporation Information
11.4.2 Vifor Description, Business Overview and Total Revenue
11.4.3 Vifor Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.4.5 Vifor Recent Development
11.5 Abbvie
11.5.1 Abbvie Corporation Information
11.5.2 Abbvie Description, Business Overview and Total Revenue
11.5.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.5.5 Abbvie Recent Development
11.6 Fresenius
11.6.1 Fresenius Corporation Information
11.6.2 Fresenius Description, Business Overview and Total Revenue
11.6.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.6.5 Fresenius Recent Development
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Description, Business Overview and Total Revenue
11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.7.5 Abbott Recent Development
11.8 Novadiol
11.8.1 Novadiol Corporation Information
11.8.2 Novadiol Description, Business Overview and Total Revenue
11.8.3 Novadiol Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.8.5 Novadiol Recent Development
11.9 Japan Tobacco Company
11.9.1 Japan Tobacco Company Corporation Information
11.9.2 Japan Tobacco Company Description, Business Overview and Total Revenue
11.9.3 Japan Tobacco Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.9.5 Japan Tobacco Company Recent Development
11.10 Daiichi-Sankyo
11.10.1 Daiichi-Sankyo Corporation Information
11.10.2 Daiichi-Sankyo Description, Business Overview and Total Revenue
11.10.3 Daiichi-Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.10.5 Daiichi-Sankyo Recent Development
11.1 Akebia
11.1.1 Akebia Corporation Information
11.1.2 Akebia Description, Business Overview and Total Revenue
11.1.3 Akebia Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.1.5 Akebia Recent Development
11.12 Spectrum
11.12.1 Spectrum Corporation Information
11.12.2 Spectrum Description, Business Overview and Total Revenue
11.12.3 Spectrum Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Spectrum Products Offered
11.12.5 Spectrum Recent Development
11.13 OPKO
11.13.1 OPKO Corporation Information
11.13.2 OPKO Description, Business Overview and Total Revenue
11.13.3 OPKO Sales, Revenue and Gross Margin (2015-2020)
11.13.4 OPKO Products Offered
11.13.5 OPKO Recent Development
11.14 Ardelyx
11.14.1 Ardelyx Corporation Information
11.14.2 Ardelyx Description, Business Overview and Total Revenue
11.14.3 Ardelyx Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Ardelyx Products Offered
11.14.5 Ardelyx Recent Development
11.15 Sanofi Genzyme
11.15.1 Sanofi Genzyme Corporation Information
11.15.2 Sanofi Genzyme Description, Business Overview and Total Revenue
11.15.3 Sanofi Genzyme Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sanofi Genzyme Products Offered
11.15.5 Sanofi Genzyme Recent Development
11.16 Amgen
11.16.1 Amgen Corporation Information
11.16.2 Amgen Description, Business Overview and Total Revenue
11.16.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Amgen Products Offered
11.16.5 Amgen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Projections by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.2.2 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Type
1.4.2 Control Hyperphosphatemia
1.4.3 Maintain Blood Calcium Levels
1.4.4 Control PTH Level
1.4.5 Correct Acidosis
1.4.6 Other
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Impact
1.6.1 How the Covid-19 is Affecting the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry
1.6.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2015-2026
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2020 Versus 2026
2.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers
3.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2015-2020)
3.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers
3.2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue in 2019
3.2.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Manufacturers
3.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2015-2020)
5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
6.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Region
8.1.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
8.1.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
8.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
9.1.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
9.1.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
9.3 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
10.1.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
10.1.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Akebia
11.1.1 Akebia Corporation Information
11.1.2 Akebia Description, Business Overview and Total Revenue
11.1.3 Akebia Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.1.5 Akebia Recent Development
11.2 Astellas
11.2.1 Astellas Corporation Information
11.2.2 Astellas Description, Business Overview and Total Revenue
11.2.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.2.5 Astellas Recent Development
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description, Business Overview and Total Revenue
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.3.5 Takeda Recent Development
11.4 Vifor
11.4.1 Vifor Corporation Information
11.4.2 Vifor Description, Business Overview and Total Revenue
11.4.3 Vifor Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.4.5 Vifor Recent Development
11.5 Abbvie
11.5.1 Abbvie Corporation Information
11.5.2 Abbvie Description, Business Overview and Total Revenue
11.5.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.5.5 Abbvie Recent Development
11.6 Fresenius
11.6.1 Fresenius Corporation Information
11.6.2 Fresenius Description, Business Overview and Total Revenue
11.6.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.6.5 Fresenius Recent Development
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Description, Business Overview and Total Revenue
11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.7.5 Abbott Recent Development
11.8 Novadiol
11.8.1 Novadiol Corporation Information
11.8.2 Novadiol Description, Business Overview and Total Revenue
11.8.3 Novadiol Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.8.5 Novadiol Recent Development
11.9 Japan Tobacco Company
11.9.1 Japan Tobacco Company Corporation Information
11.9.2 Japan Tobacco Company Description, Business Overview and Total Revenue
11.9.3 Japan Tobacco Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.9.5 Japan Tobacco Company Recent Development
11.10 Daiichi-Sankyo
11.10.1 Daiichi-Sankyo Corporation Information
11.10.2 Daiichi-Sankyo Description, Business Overview and Total Revenue
11.10.3 Daiichi-Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.10.5 Daiichi-Sankyo Recent Development
11.1 Akebia
11.1.1 Akebia Corporation Information
11.1.2 Akebia Description, Business Overview and Total Revenue
11.1.3 Akebia Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
11.1.5 Akebia Recent Development
11.12 Spectrum
11.12.1 Spectrum Corporation Information
11.12.2 Spectrum Description, Business Overview and Total Revenue
11.12.3 Spectrum Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Spectrum Products Offered
11.12.5 Spectrum Recent Development
11.13 OPKO
11.13.1 OPKO Corporation Information
11.13.2 OPKO Description, Business Overview and Total Revenue
11.13.3 OPKO Sales, Revenue and Gross Margin (2015-2020)
11.13.4 OPKO Products Offered
11.13.5 OPKO Recent Development
11.14 Ardelyx
11.14.1 Ardelyx Corporation Information
11.14.2 Ardelyx Description, Business Overview and Total Revenue
11.14.3 Ardelyx Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Ardelyx Products Offered
11.14.5 Ardelyx Recent Development
11.15 Sanofi Genzyme
11.15.1 Sanofi Genzyme Corporation Information
11.15.2 Sanofi Genzyme Description, Business Overview and Total Revenue
11.15.3 Sanofi Genzyme Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sanofi Genzyme Products Offered
11.15.5 Sanofi Genzyme Recent Development
11.16 Amgen
11.16.1 Amgen Corporation Information
11.16.2 Amgen Description, Business Overview and Total Revenue
11.16.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Amgen Products Offered
11.16.5 Amgen Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Estimates and Projections by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.2.2 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segments
Table 2. Ranking of Global Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Control Hyperphosphatemia
Table 5. Major Manufacturers of Maintain Blood Calcium Levels
Table 6. Major Manufacturers of Control PTH Level
Table 7. Major Manufacturers of Correct Acidosis
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players to Combat Covid-19 Impact
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Application 2020-2026 (MT)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Regions 2015-2020 (MT)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Regions (2015-2020)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers (2015-2020)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2019)
Table 23. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (2015-2020) (USD/Kg)
Table 26. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type
Table 28. Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Type (2015-2020)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Type (2015-2020)
Table 34. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Application (2015-2020)
Table 37. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 38. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 39. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 41. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 43. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 44. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 45. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 51. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 52. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2015-2020) (MT)
Table 54. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 58. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 60. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 61. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 62. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 65. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 66. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 67. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 68. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 70. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 74. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 76. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 77. Akebia Corporation Information
Table 78. Akebia Description and Major Businesses
Table 79. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 80. Akebia Product
Table 81. Akebia Recent Development
Table 82. Astellas Corporation Information
Table 83. Astellas Description and Major Businesses
Table 84. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 85. Astellas Product
Table 86. Astellas Recent Development
Table 87. Takeda Corporation Information
Table 88. Takeda Description and Major Businesses
Table 89. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 90. Takeda Product
Table 91. Takeda Recent Development
Table 92. Vifor Corporation Information
Table 93. Vifor Description and Major Businesses
Table 94. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 95. Vifor Product
Table 96. Vifor Recent Development
Table 97. Abbvie Corporation Information
Table 98. Abbvie Description and Major Businesses
Table 99. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Abbvie Product
Table 101. Abbvie Recent Development
Table 102. Fresenius Corporation Information
Table 103. Fresenius Description and Major Businesses
Table 104. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Fresenius Product
Table 106. Fresenius Recent Development
Table 107. Abbott Corporation Information
Table 108. Abbott Description and Major Businesses
Table 109. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Abbott Product
Table 111. Abbott Recent Development
Table 112. Novadiol Corporation Information
Table 113. Novadiol Description and Major Businesses
Table 114. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Novadiol Product
Table 116. Novadiol Recent Development
Table 117. Japan Tobacco Company Corporation Information
Table 118. Japan Tobacco Company Description and Major Businesses
Table 119. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Japan Tobacco Company Product
Table 121. Japan Tobacco Company Recent Development
Table 122. Daiichi-Sankyo Corporation Information
Table 123. Daiichi-Sankyo Description and Major Businesses
Table 124. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. Daiichi-Sankyo Product
Table 126. Daiichi-Sankyo Recent Development
Table 127. Shield Corporation Information
Table 128. Shield Description and Major Businesses
Table 129. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. Shield Product
Table 131. Shield Recent Development
Table 132. Spectrum Corporation Information
Table 133. Spectrum Description and Major Businesses
Table 134. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 135. Spectrum Product
Table 136. Spectrum Recent Development
Table 137. OPKO Corporation Information
Table 138. OPKO Description and Major Businesses
Table 139. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 140. OPKO Product
Table 141. OPKO Recent Development
Table 142. Ardelyx Corporation Information
Table 143. Ardelyx Description and Major Businesses
Table 144. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 145. Ardelyx Product
Table 146. Ardelyx Recent Development
Table 147. Sanofi Genzyme Corporation Information
Table 148. Sanofi Genzyme Description and Major Businesses
Table 149. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 150. Sanofi Genzyme Product
Table 151. Sanofi Genzyme Recent Development
Table 152. Amgen Corporation Information
Table 153. Amgen Description and Major Businesses
Table 154. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 155. Amgen Product
Table 156. Amgen Recent Development
Table 157. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Regions (2021-2026) (MT)
Table 158. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Regions (2021-2026)
Table 159. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 160. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Regions (2021-2026)
Table 161. North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 162. North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 164. Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2021-2026) (MT)
Table 166. Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 167. Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 168. Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 170. Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 172. Key Challenges
Table 173. Market Risks
Table 174. Main Points Interviewed from Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players
Table 175. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List
Table 176. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segments
Table 2. Ranking of Global Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Control Hyperphosphatemia
Table 5. Major Manufacturers of Maintain Blood Calcium Levels
Table 6. Major Manufacturers of Control PTH Level
Table 7. Major Manufacturers of Correct Acidosis
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players to Combat Covid-19 Impact
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Growth Rate by Application 2020-2026 (MT)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Regions 2015-2020 (MT)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Regions (2015-2020)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers (2015-2020)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2019)
Table 23. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (2015-2020) (USD/Kg)
Table 26. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type
Table 28. Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Type (2015-2020)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Type (2015-2020)
Table 34. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Application (2015-2020)
Table 37. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 38. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 39. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 41. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 43. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 44. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 45. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 51. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 52. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2015-2020) (MT)
Table 54. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 58. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 60. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 61. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 62. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 65. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 66. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 67. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 68. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2015-2020) (MT)
Table 70. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2015-2020) (MT)
Table 74. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2015-2020) (MT)
Table 76. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Table 77. Akebia Corporation Information
Table 78. Akebia Description and Major Businesses
Table 79. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 80. Akebia Product
Table 81. Akebia Recent Development
Table 82. Astellas Corporation Information
Table 83. Astellas Description and Major Businesses
Table 84. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 85. Astellas Product
Table 86. Astellas Recent Development
Table 87. Takeda Corporation Information
Table 88. Takeda Description and Major Businesses
Table 89. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 90. Takeda Product
Table 91. Takeda Recent Development
Table 92. Vifor Corporation Information
Table 93. Vifor Description and Major Businesses
Table 94. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 95. Vifor Product
Table 96. Vifor Recent Development
Table 97. Abbvie Corporation Information
Table 98. Abbvie Description and Major Businesses
Table 99. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Abbvie Product
Table 101. Abbvie Recent Development
Table 102. Fresenius Corporation Information
Table 103. Fresenius Description and Major Businesses
Table 104. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Fresenius Product
Table 106. Fresenius Recent Development
Table 107. Abbott Corporation Information
Table 108. Abbott Description and Major Businesses
Table 109. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Abbott Product
Table 111. Abbott Recent Development
Table 112. Novadiol Corporation Information
Table 113. Novadiol Description and Major Businesses
Table 114. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Novadiol Product
Table 116. Novadiol Recent Development
Table 117. Japan Tobacco Company Corporation Information
Table 118. Japan Tobacco Company Description and Major Businesses
Table 119. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. Japan Tobacco Company Product
Table 121. Japan Tobacco Company Recent Development
Table 122. Daiichi-Sankyo Corporation Information
Table 123. Daiichi-Sankyo Description and Major Businesses
Table 124. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. Daiichi-Sankyo Product
Table 126. Daiichi-Sankyo Recent Development
Table 127. Shield Corporation Information
Table 128. Shield Description and Major Businesses
Table 129. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. Shield Product
Table 131. Shield Recent Development
Table 132. Spectrum Corporation Information
Table 133. Spectrum Description and Major Businesses
Table 134. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 135. Spectrum Product
Table 136. Spectrum Recent Development
Table 137. OPKO Corporation Information
Table 138. OPKO Description and Major Businesses
Table 139. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 140. OPKO Product
Table 141. OPKO Recent Development
Table 142. Ardelyx Corporation Information
Table 143. Ardelyx Description and Major Businesses
Table 144. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 145. Ardelyx Product
Table 146. Ardelyx Recent Development
Table 147. Sanofi Genzyme Corporation Information
Table 148. Sanofi Genzyme Description and Major Businesses
Table 149. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 150. Sanofi Genzyme Product
Table 151. Sanofi Genzyme Recent Development
Table 152. Amgen Corporation Information
Table 153. Amgen Description and Major Businesses
Table 154. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 155. Amgen Product
Table 156. Amgen Recent Development
Table 157. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Regions (2021-2026) (MT)
Table 158. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Regions (2021-2026)
Table 159. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 160. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Regions (2021-2026)
Table 161. North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 162. North America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 164. Europe: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2021-2026) (MT)
Table 166. Asia Pacific: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 167. Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 168. Latin America: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2021-2026) (MT)
Table 170. Middle East and Africa: Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 172. Key Challenges
Table 173. Market Risks
Table 174. Main Points Interviewed from Key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players
Table 175. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List
Table 176. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Picture
Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2020 & 2026
Figure 3. Control Hyperphosphatemia Product Picture
Figure 4. Maintain Blood Calcium Levels Product Picture
Figure 5. Control PTH Level Product Picture
Figure 6. Correct Acidosis Product Picture
Figure 7. Other Product Picture
Figure 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Drug Stores
Figure 13. Other
Figure 14. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size 2015-2026 (US$ Million)
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2015-2026 (MT)
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue in 2019
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2019
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2015-2020)
Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type in 2019
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Price Range (2015-2020)
Figure 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application in 2019
Figure 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2015-2020)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2019
Figure 34. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 35. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 37. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 38. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 39. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 41. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 43. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 44. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 45. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 48. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 49. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 51. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 53. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 55. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 57. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 59. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 60. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 63. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 64. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 65. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 71. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 87. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 88. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 89. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 91. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 92. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 93. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 95. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 97. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 99. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 100. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 101. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 104. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 105. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 107. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 109. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 111. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 112. Akebia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Vifor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Abbott Total Revenue
Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Picture
Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2020 & 2026
Figure 3. Control Hyperphosphatemia Product Picture
Figure 4. Maintain Blood Calcium Levels Product Picture
Figure 5. Control PTH Level Product Picture
Figure 6. Correct Acidosis Product Picture
Figure 7. Other Product Picture
Figure 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Drug Stores
Figure 13. Other
Figure 14. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size 2015-2026 (US$ Million)
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2015-2026 (MT)
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2015-2020)
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2015-2020)
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue in 2019
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2015-2020)
Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2019
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2015-2020)
Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type in 2019
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Price Range (2015-2020)
Figure 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2015-2020)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application in 2019
Figure 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2015-2020)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2019
Figure 34. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 35. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 37. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 38. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 39. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 41. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 43. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 44. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 45. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 47. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 48. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 49. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 51. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 53. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 55. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 57. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 59. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 60. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2019
Figure 63. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in 2019
Figure 64. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 65. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 71. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 87. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 88. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 89. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 91. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 92. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 93. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 95. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 97. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 99. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 100. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2015-2020 (MT)
Figure 101. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2019
Figure 104. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 105. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 107. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate (2015-2020) (MT)
Figure 109. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2019
Figure 111. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2019
Figure 112. Akebia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Vifor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Abbott Total Revenue
